In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Medical Services Patients & Visitors Health Library For Medical Professionals Quality About Us PhysicianLink
Text Size:  -   +  |  Print Page  |  Email Page

Non-Small Cell Lung Cancer



A Randomized Phase III Double Blind Trial Evaluating Selective Cox-2 Inhibition in Cox-2 Expressing Advanced Non-Small Cell Lung Cancer.

 

     For additional information please contact Nurdan IIgaz, Clinical Research Coordinator, at 859-260-6406
    
 REF#  CBH 11-985

 

Phase 1b/2, Multicenter, Open-label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects with Previously Untreated Extensive Stage Small-cell Lung Cancer.

 

     For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196. 
     REF# BHL-13-1129